Whole-genome approach implicates CD44 in cellular resistance to carboplatin

Carboplatin is a chemotherapeutic agent used in the management of many cancers, yet treatment is limited by resistance and toxicities. To achieve a better understanding of the genetic contribution to carboplatin resistance or toxicities, lymphoblastoid cell lines from 34 large Centre d'Etude du...

Descripción completa

Detalles Bibliográficos
Autores principales: Shukla, Sunita J, Duan, Shiwei, Wu, Xiaolin, Badner, Judith A, Kasza, Kristen, Dolan, M Eileen
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683878/
https://www.ncbi.nlm.nih.gov/pubmed/19164090
http://dx.doi.org/10.1186/1479-7364-3-2-128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683878/
https://www.ncbi.nlm.nih.gov/pubmed/19164090
http://dx.doi.org/10.1186/1479-7364-3-2-128

Ejemplares similares